A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease

NCT06481306 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

184

Enrollment

INDUSTRY

Sponsor class

Conditions

Anemia, Sickle Cell
Healthy Volunteers

Interventions

DRUG: BMS-986470
DRUG: Placebo
DRUG: Famotidine

Sponsor

Bristol-Myers Squibb